Pediatric Pulmonology year in review 2015: Part 4

Adrienne P Savant1,2, Susanna A McColley1,2,3

  • 1Division of Pulmonary Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Illinois.

Insights

This review covers 2015 research on cystic fibrosis (CF), a genetic disorder affecting the lungs and other organs. It includes key studies from Pediatric Pulmonology and other relevant journals.

Area of Science:

  • Pediatric Pulmonology
  • Genetics
  • Respiratory Medicine

Background:

  • Cystic Fibrosis (CF) is a complex genetic disorder.
  • Understanding recent advancements is crucial for patient care.
  • The year 2015 saw significant research output in the field.

Purpose of the Study:

  • To summarize and highlight key research findings in cystic fibrosis published in 2015.
  • To provide an overview of important studies from Pediatric Pulmonology and other journals.
  • To consolidate current knowledge for researchers and clinicians.

Main Methods:

  • Literature review of articles published in Pediatric Pulmonology in 2015.
  • Inclusion of relevant studies from other peer-reviewed journals.
  • Synthesis of research themes and significant findings.

Main Results:

  • Key advancements in understanding CF pathophysiology were presented.
  • New therapeutic strategies and clinical trial results were discussed.
  • Research covered diverse aspects of CF, including genetics, diagnostics, and treatment.

Conclusions:

  • The 2015 literature demonstrates continued progress in cystic fibrosis research.
  • These findings contribute to improved management and potential cures for CF.
  • Ongoing research is vital for addressing the challenges of this disease.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K